OPUVIZ™, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen’s second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency ...

Dmytro Tyshchenko/Shutterstock Weed is all the buzz in Florida year. The Florida Supreme Court gave the final go ahead for ...

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

Lynne Merriam was working as a nurse in an emergency room in the early 1990s when a leadership position in the research ...

Cannabis-based medicines specialist Celadon Pharmaceuticals has announced a partnership with Valeos Pharma, a Danish ...